San Diego Theatres Inc
Analysis
San Diego Theatres Inc is a registered charity in United States, based in San Diego, CA. It received its IRS tax-exemption ruling in May 2004, 22 years ago. Its declared purposes cover arts, culture and humanities, which this site groups under arts, culture, heritage and science. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending June 2024, San Diego Theatres Inc reported income of $15.0m and spending of $11.6m, leaving 22% of income unspent that year. Across the 5 years on record, from June 2020 to June 2024, income grew from $7.7m to $15.0m (+95%), an average of +18% a year. The sharpest change came in the year to June 2022, when income rose by 214%. Over the whole period it spent 85% of the income it received.
Among 45,478 United States charities whose main cause is arts, culture, heritage and science and that reported income, San Diego Theatres Inc sits at the 99th percentile: it is larger than about 98% of them. Against every charity in United States with reported income it ranks in the 96th percentile, and in the 97th percentile within CA. Charities of a similar size with the same main cause include Keystone Symposia on Molecular and Cellular Biology ($14.9m), Salzburg Global Seminar Inc ($15.0m) and Terc Inc ($14.9m).
On its Form 990 for the period ending June 2024, revenue came from contributions and grants 1.0% and program service revenue 98% of the total. Compensation of current officers, directors and key employees was $873k (7.5% of expenses). Other salaries and wages came to $3.5m. At year end it held assets of $25.0m against liabilities of $8.4m, net assets of $16.6m. It reported 177 employees.
Income and spending
Where the income comes from
- Contributions & grants 1.0%
- Program services 98%
- Other 1.4%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Keystone Symposia on Molecular and Cellular Biology | Silverthorne | $14.9m |
| Salzburg Global Seminar Inc | Washington | $15.0m |
| Terc Inc | Cambridge | $14.9m |
| Equis Institute | Washington | $15.0m |